Valuation GC Corp.

Stocks

End-of-day quote Korea S.E. Other stock markets 06/08/2026			5-day change	1st Jan Change
10,260.00 ^KRW	+1.99%		+13.50%	-35.55%

06-11	GC Corp.(KOSE:A005250) dropped from KOSPI 200 Index	CI
05-27	Green Cross Holdings to divest 460 billion won worth of stake in Curevo	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,904,748	1,238,276	775,668	745,892	787,881	725,306
Change	-	-34.99%	-37.36%	-3.84%	5.63%	-7.94%
Enterprise Value (EV) ¹	2,481,633	1,885,666	1,633,562	1,829,947	1,829,909	2,119,318
Change	-	-24.02%	-13.37%	12.02%	-0%	15.82%
P/E	11.1x	22.6x	23.8x	-13.6x	33.4x	-10.4x
PBR	2.05x	1.21x	0.74x	0.76x	0.79x	0.79x
PEG	-	-0.3x	-0.6x	0x	-0x	0x
Capitalization / Revenue	1.11x	0.67x	0.37x	0.36x	0.36x	0.3x
EV / Revenue	1.44x	1.02x	0.79x	0.89x	0.83x	0.86x
EV / EBITDA	20.1x	12.7x	11x	25.1x	19.7x	14.9x
EV / EBIT	35.1x	21.9x	23.3x	-83.8x	-167x	60.6x
EV / FCF	-27.1x	-52.3x	2,448x	-10.2x	-49.2x	-22.5x
FCF Yield	-3.69%	-1.91%	0.04%	-9.84%	-2.03%	-4.45%
Dividend per Share ²	500	400	300	300	500	-
Rate of return	1.2%	1.47%	1.76%	1.83%	2.89%	-
EPS ²	3,743	1,201	715.6	-1,203	518.2	-1,531
Distribution rate	13.4%	33.3%	41.9%	-24.9%	96.5%	-
Net sales ¹	1,719,326	1,840,559	2,079,560	2,057,936	2,204,855	2,451,476
EBITDA ¹	123,495	148,443	148,876	73,017	92,755	142,156
EBIT ¹	70,664	85,999	70,221	-21,830	-10,987	34,990
Net income ¹	170,960	55,270	32,823	-54,136	24,025	-69,513
Net Debt ¹	576,885	647,390	857,894	1,084,055	1,042,028	1,394,012
Reference price ²	41,500.00	27,150.00	17,000.00	16,350.00	17,320.00	15,920.00
Nbr of stocks (in thousands)	45,402	45,402	45,402	45,402	45,402	45,402
Announcement Date	17/03/21	21/03/22	21/03/23	20/03/24	18/03/25	18/03/26

¹KRW in Million²KRW

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GC CORP.	-	-	-	-	322M
ELI LILLY AND COMPANY	34.15x	12.3x	24.81x	0.59%	1,043B
JOHNSON & JOHNSON	28.65x	6.33x	17.69x	2.09%	621B
ABBVIE INC.	32.22x	7.27x	14.86x	2.81%	435B
ROCHE HOLDING AG	20.32x	4.82x	11.94x	2.74%	361B
NOVARTIS AG	21.88x	5.66x	14.13x	2.83%	293B
ASTRAZENECA PLC	20.89x	4.29x	12.19x	2.05%	251B
AMGEN INC.	25.57x	6.75x	12.03x	2.47%	220B
NOVO NORDISK A/S	12.99x	4.77x	10.28x	3.82%	201B
GILEAD SCIENCES, INC.	-41.73x	5.88x	33.15x	2.46%	164B
Average	17.22x	6.45x	16.79x	2.43%	358.95B
Weighted average by Cap.	24.48x	7.75x	18.10x	2%